Jeana DaRe, PhD, FACMG is the Vice President of Laboratory Medicine at Progenity. She is responsible for leading the Laboratory Director team, overseeing the Medical Affairs team, and bringing clinical molecular genetics expertise to Progenity’s new product development and commercialization pipeline. She joined the company in 2014 bringing with her a background in laboratory leadership, next-generation sequencing, variant interpretation, and commercialization of genetic tests.

Dr. DaRe was previously Laboratory Director at Transgenomic, where she helped bring one of the first large next-generation sequencing panels to the clinical laboratory industry. Dr. DaRe obtained certification by the American Board of Medical Genetics in Clinical Molecular Genetics, after completing her clinical training through a joint program located at Providence Sacred Heart Medical Center and Signature Genomics Laboratories in Spokane, WA. She earned her doctoral degree in Genetics from Case Western Reserve University, in Cleveland, OH.

Thomas Monroe, PhD is Senior Laboratory Director at Progenity. He joined the organization in 2015 and brings his experience and expertise in NIPT analysis to support Progenity’s launch and continuing advancements in Non-Invasive Prenatal Testing (NIPT).

Prior to joining the Progenity team, Dr. Monroe spent over 20 years in the molecular diagnostics arena. He was Laboratory Director for Sequenom in North Carolina where he spent over three years working with the developers of the first commercially available NIPT assay. He established the first clinical molecular laboratory in Western Michigan at the former Butterworth Hospital (currently part of the Spectrum Health System). Earlier in his career, Dr. Monroe was very active in clinical research, at the Upjohn Company and serving for over a decade as the Director of the Ferguson Digestive Disease Institutes. Dr. Monroe received a Bachelor of Science degree in 1984 from The Pennsylvania State University, a PhD in Microbiology from Colorado State University conferred in 1990 and currently holds New York State Certificates of Qualification in Genetic Testing and Immunohematology.

Lisa McDaniel, PhD is Senior Laboratory Director at Progenity, Inc. Her current responsibilities include analysis and reporting of patient results, development of processes to ensure accurate results and improve test performance and working with R&D to introduce and validate new assays. She has more than 30 years of experience in molecular genetics and is board certified in Clinical Molecular Genetics.

Dr. McDaniel was previously Laboratory Director at Signature Genomic Laboratories, working with constitutional microarrays, developing targeted cancer microarrays, as well as molecular assays. Dr. McDaniel also worked at the University of Texas Southwestern Medical Center in Dallas where she was a lecturer and an assistant professor working on mapping human disease genes and mouse models for xeroderma pigmentosum, Cockayne syndrome, Roberts syndrome, Bloom syndrome and other disorders. Dr. McDaniel holds a bachelor’s degree and a PhD in Genetics from the University of California at Davis. She completed a fellowship at Providence Sacred Heart Medical Center in Spokane, Washington and a post-doctoral fellowship at the University of Maryland at Baltimore Medical Center.

Priscilla Fernandes, PhD is Associate Laboratory Director at Progenity. Her primary responsibility is the daily review of patient data and report sign-out. She also contributes to research for new product development and post-launch product quality monitoring.

Dr. Fernandes was previously laboratory director with Myriad Genetic Laboratories, where she gained expertise in hereditary cancer genetic testing as well as classification and reclassification of genetic variants. She earned her doctoral degree in Molecular and Medical Genetics from Oregon Health and Science University in Portland. Dr. Fernandes is board certified by the American Board of Medical Genetics and Genomics (ABMGG) and is a Fellow of the American College of Medical Genetics (ACMG) following her post-doctoral clinical training at Baylor College of Medicine.